ICD-10 Coding for Antinuclear Factor Positive(M35.8, R76.0, R76.0B)
Learn about ICD-10 coding for antinuclear factor positive, including when to use R76.0 vs. R76.8, documentation requirements, and clinical validation.
Complete code families applicable to Antinuclear Factor Positive
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R76.0 | Raised antibody titer | Use when ANA titer is elevated but no specific pattern is identified. |
|
| R76.8 | Other specified abnormal immunological findings | Use when ANA test shows specific patterns such as speckled or homogeneous. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAntinuclear Factor Positive
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Antinuclear Factor Positive.
Failing to document ANA pattern when present.
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential reimbursement issues due to incorrect coding.
Mitigation
Train staff on importance of documenting ANA patterns., Use templates that prompt for pattern documentation.
Using R76.0 for specific ANA patterns.
Impact
Reimbursement: May lead to denial if specific patterns are not coded correctly., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use R76.8 when specific patterns are identified.
Incorrect coding of ANA patterns
Impact
Using R76.0 instead of R76.8 when specific patterns are present.
Mitigation
Ensure documentation includes specific ANA patterns.